Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Aug 14, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Aug 13, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
- Aug 13, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record83723 flagged findings
Reported transactions (Form 4)80since May 25, 2023 · and 9 other holdings
Corporate events (8-K)30since Feb 4, 2022
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-05-26share offering or dilution eventrecentOpen filing ↗“…number of shares of common stock issuable upon exercise is subject to adjustment, as set forth in the pre-funded warrant, in the…”
+1 more passage from the same document
- “…of our common stock that are issuable from time to time upon exercise of the pre-funded warrants. Our common stock is listed on The…”
- 2026-05-26capital return (buybacks/dividends)recentOpen filing ↗“…price; • the dividend rate, period and payment date, and method of calculation for dividends; • whether dividends will be…”
+1 more passage from the same document
- “…• whether dividends will be cumulative or non-cumulative and, if cumulative, the date from which dividends will accumulate; • the…”
- 2026-05-26reverse splitrecentOpen filing ↗“…transaction is to be settled in securities, in cash or otherwise; (vi) announce the offering of any shares of common stock or related…”
- 2026-05-22share offering or dilution eventrecentOpen filing ↗“…number of shares of common stock issuable upon exercise is subject to adjustment, as set forth in the pre-funded warrant, in the…”
+1 more passage from the same document
- “…of our common stock that are issuable from time to time upon exercise of the pre-funded warrants. Our common stock is listed on The…”
- 2026-05-22capital return (buybacks/dividends)recentOpen filing ↗“…price; • the dividend rate, period and payment date, and method of calculation for dividends; • whether dividends will be…”
+1 more passage from the same document
- “…• whether dividends will be cumulative or non-cumulative and, if cumulative, the date from which dividends will accumulate; • the…”
- 2026-05-22reverse splitrecentOpen filing ↗“…transaction is to be settled in securities, in cash or otherwise; (vi) announce the offering of any shares of common stock or related…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
Reverse splits in 5 years
1 reverse split in 5 years (1:12 on Feb 12, 2024) · 1:12 cumulative
The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).
Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.
The 25 most recent filings (of 837)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Aug 14, 268-K/A ↗Current report · Results · amendment
- Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Paradigm BioCapital Advisors LP · 7.8% · event on Jun 30, 26 · amendment
- Aug 13, 26SCHEDULE 13G/A ↗Passive stake · JANUS HENDERSON GROUP Ltd. · 6.9% · event on Jun 30, 26 · amendment
- Aug 13, 2610-Q ↗Quarterly report
- Aug 13, 268-K ↗Current report · Completed an acquisition or disposal
- Aug 4, 26SCHEDULE 13G/A ↗Passive stake · Farallon Capital Management, L.L.C. · 8.1% · event on Jun 30, 26 · amendment
Insider transaction · 12 Form 4 filingsshow all 12hide
- Jun 18, 26Form 4 ↗Insider transaction
- Jun 5, 26Form 4 ↗Insider transaction
- Jun 5, 26Form 4 ↗Insider transaction
- Jun 5, 26Form 4 ↗Insider transaction
- Jun 5, 26Form 4 ↗Insider transaction
- Jun 5, 26Form 4 ↗Insider transaction
- Jun 5, 26Form 4 ↗Insider transaction
- Jun 5, 26Form 4 ↗Insider transaction
- Jun 5, 26Form 4 ↗Insider transaction
- Jun 5, 26Form 4 ↗Insider transaction
- Jun 5, 26Form 4 ↗Insider transaction
- Jun 5, 26Form 4 ↗Insider transaction
- Jun 5, 268-K ↗Current report · A senior executive left or was appointed
- May 27, 26Form 4 ↗Insider transaction
- May 27, 26SCHEDULE 13D/A ↗Stake with intent to influence · GILEAD SCIENCES, INC. · 25.1% · event on May 22, 26 · amendment
- May 26, 268-K ↗Current report · Entered a material agreement
- May 26, 26424B5 ↗Securities offering
- May 22, 26424B5 ↗Securities offering
- May 22, 268-K ↗Current report · Communication to the market · Other events
837 filings on record, the oldest from Jul 20, 10.
Listing the 25 most recent filings of the 837 on record.
33748
- Aug 13, 26Completed an acquisition or disposal+1 more in the same filing8-K 2.01 ↗
- Jun 5, 26A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- May 26, 26Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Mar 30, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Aug 11, 25Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Jun 9, 25A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
4 material agreements entered2024 – 2025show all 4hide
- Jan 3, 25Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Dec 19, 24Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Nov 7, 24Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Jun 18, 24Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Jun 3, 24A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Mar 15, 24A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Jan 17, 24A material agreement was terminated8-K 1.02 ↗
- Dec 7, 23A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Oct 17, 23Entered a material agreement+2 more in the same filing8-K 1.01 ↗
8 older filings not shown · The record reaches back to Jan 20, 11.
Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.
- Sep 29, 23Listing notice (8-K 3.01)8-K 3.01 ↗
- Jul 20, 22Restructuring plan with committed costs+3 more in the same filing8-K 2.05 ↗
- Dec 8, 20Restructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
The full record holds 3 stress filings.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- GILEAD SCIENCES, INC.25.1%May 22, 26SCHEDULE 13D/A ↗2 earlier filings
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- Commodore Capital LP9.9%Aug 8, 25SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
- RA Capital Management, L.P.9.5%Aug 11, 25SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
- Farallon Capital Management, L.L.C.8.1%Jun 30, 26SCHEDULE 13G/A ↗27 co-filers on this document — the figure is the largest single stake, not their sum.
- Paradigm BioCapital Advisors LP7.8%Jun 30, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- Dapice Joshua J.7.8%Dec 31, 25SCHEDULE 13G/A ↗29 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
show 3 more holdershide
- JANUS HENDERSON GROUP Ltd.6.9%Jun 30, 26SCHEDULE 13G/A ↗1 earlier filing
- Armistice Capital, LLC5.0%Dec 31, 24SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
- Alexander Schornstein3.5%Aug 11, 25SCHEDULE 13G/A ↗3 earlier filings
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
- Jun 17, 26Sell$674Jeanette M BjorkquistPFO and PAO↗
- Mar 30, 26Sell$5KNicole S WhiteChief Manufacturing Officer↗
- Mar 30, 26Sell$247Nicole S WhiteChief Manufacturing Officer↗
- Mar 30, 26Sell$8KJeanette M BjorkquistPFO and PAO↗
- Mar 30, 26Sell$440Jeanette M BjorkquistPFO and PAO↗
- Aug 8, 25Buyamount n/aGILEAD SCIENCES, INC.↗
- Mar 31, 25Sell$2KNicole S WhiteChief Manufacturing Officer↗
- Mar 31, 25Sell$3KJason A OkazakiCEO and President↗
- Mar 31, 25Sell$2KJeanette M BjorkquistPrincipal Accounting Officer↗
- Mar 31, 25Sell$7KJohn G McHutchison↗
- Dec 30, 24Buy$50KMichael Houghton↗
- Dec 19, 24Buy$20.1MGILEAD SCIENCES, INC.↗
There are 15 more transactions in this stretch.
Stock compensation, tax and giftsshow the 13 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- May 26, 26Compensation$12.5MGILEAD SCIENCES, INC.↗
- Mar 29, 26Compensationamount n/aJason A OkazakiCEO and President↗
- Mar 29, 26Compensationamount n/aWilliam E Delaney IVChief Scientific Officer↗
- Mar 29, 26Compensationamount n/aAnuj GaggarChief Medical Officer↗
- Mar 29, 26Compensationamount n/aNicole S WhiteChief Manufacturing Officer↗
- Mar 29, 26Compensationamount n/aJeanette M BjorkquistPFO and PAO↗
- Mar 29, 26Compensationamount n/aJason A OkazakiCEO and President↗
- Mar 29, 26Compensationamount n/aWilliam E Delaney IVChief Scientific Officer↗
- Mar 29, 26Compensationamount n/aJeanette M BjorkquistPFO and PAO↗
- Mar 29, 26Compensationamount n/aNicole S WhiteChief Manufacturing Officer↗
- Mar 29, 26Compensationamount n/aAnuj GaggarChief Medical Officer↗
- Jun 16, 25Compensationamount n/aJeanette M BjorkquistPFO and PAO↗
- Mar 29, 25Compensationamount n/aJeanette M BjorkquistPrincipal Accounting Officer↗
The full record holds 85 transactions and goes back to Feb 16, 23.
Its sector and its market
Assembly Biosciences Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Assembly Biosciences Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Assembly Biosciences Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 837 documents on file, from Jul 20, 2010 to Aug 14, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.